Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT04175613

Public ClinicalTrials.gov record NCT04175613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 9:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multi Center, Open-label, Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Study identification

NCT ID
NCT04175613
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
160 participants

Conditions and interventions

Conditions

Interventions

  • Apremilast Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2019
Primary completion
Oct 29, 2025
Completion
Dec 11, 2025
Last update posted
Dec 21, 2025

2019 – 2025

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Phoenix Childrens Hospital Phoenix Arizona 85016
Johnson Dermatology Clinic Fort Smith Arkansas 72916
First OC Dermatology Irvine California 92697
Stanford University School of Medicine Palo Alto California 94304
California Dermatology Institute Thousand Oaks California 91320
Solutions Through Advanced Research Inc Jacksonville Florida 32256
Ciocca Dermatology Miami Florida 33173
Skin Care Physicians of Georgia Macon Georgia 31217
Dawes Fretzin Dermatology Group Inc Indianapolis Indiana 46256
Wright State Physicians Fairborn Ohio 45324
Medical University of South Carolina Charleston South Carolina 29425
Driscoll Childrens Hospital San Antonio Texas 78218
University of Wisconsin Hospital and Clinics Madison Wisconsin 53715-1375

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04175613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2025 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04175613 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →